Four drugs companies avoid a trial over their role in the US opioid crisis by striking a deal.
ADVERTISEMENT
ADVERTISEMENT
Drugs firms reach $260m US opioid settlement
Four drugs companies avoid a trial over their role in the US opioid crisis by striking a deal.